To evaluate whether the epithelial-mesenchymal transition played a part in the invasiveness of GC, we monitored specific epithelial–mesenchymal transition markers such as E-cadherin, N-cadherin, and vimentin. The gene discussed is CDH1; the disease is gastric cancer.